Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -3,630
▲ 80% vs 2024
Profit
Caution€ -4,810
▲ 75% vs 2024
Debts
High€ 135,580
▲ 22% vs 2024
S-FORM PHARMA from Etterbeek, company number BE0715471307, closed financial year 2025 with a result of € -4,810 after tax. For that financial year S-FORM PHARMA recorded a gross margin of € -3,630 and equity of € -115,150. Compared with financial year 2024, the result moved from € -19,583 to € -4,810. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
What happened at S-FORM PHARMA?
What happened at S-FORM PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 4,810. filed late Source: NBB ↗
- Tatyana ANDREEVA became a director. NBB
- Marcio SCORSIN became a director. NBB
- Eric HALIOUA stepped down as director. NBB
- New establishment in Etterbeek. KBO
- Eric HALIOUA became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 7,092 loss in 2021 to € 4,810 loss in 2025.
A new publication or filing at S-FORM PHARMA? We notify you, reason included.
Follow S-FORM PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind S-FORM PHARMA are Tatyana ANDREEVA and Marcio SCORSIN.
Directors
According to the 2025 annual accounts
Tatyana ANDREEVA
Director
since 2024
Marcio SCORSIN
Director
since 2024
since 2018 · until 2024
Establishments
Establishment units
Physical locations of this company
Louis Schmidtlaan 87
1040 Etterbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 38 companies are registered at this address.
Organisatiebureel A.D.
FEDERATION EUROPEENNE DES ASSOCIATIONS DES ETABLISSEMENTS DE CREDIT EUROFINAS ASS INT
€ 462,531 gross margin · 2025
SEGRO BELGIUM
€ -35,308 gross margin · 2025
FEDERATION EUROPEENNE DES ASSOCIATIONS DES ETABLISSEMENTS DE LEASING - EUROPESE FEDERATIE VAN VERENIGINGEN VAN LEASINGONDERNEMINGEN - EUROPEAN FEDERATIONOF LEAS
€ 866,930 gross margin · 2025
IMMOBILIERE PARMA-IMMOBILIEN PARMA
€ -5,692 gross margin · 2024
+33 more
Details
- Company number
- 0715.471.307
- VAT number
- BE 0715.471.307
- Registered office
- Louis Schmidtlaan 87, 1040 Etterbeek
- Names & denominations
- S-FORM PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 December 2018
- Peppol
- Not registered
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Vervaardiging van overige farmaceutische producten
Handelsbemiddeling in de niet-gespecialiseerde groothandel